Fundraising Fox
StratifAI
Berlin, DE · Founded 2023 · 6 known investors
Find your way into StratifAI
Sign up to see every warm intro you have to StratifAI
- Paths you didn't know you had: your email and LinkedIn already hold routes to the StratifAI team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
StratifAI develops AI-driven multimodal biomarkers for precision oncology, using its platform to link routine H&E histology and RNASeq gene expression data to patient outcomes for prognostic and predictive insights. Its offerings target cancer diagnostics for oncology institutions and pharmaceutical companies, with an initial focus on breast cancer recurrence risk.
Founders & leadership
StratifAI was founded in 2023 by Daniel Truhn, Firas Khader, Jakob Nikolas Kather, and Omar El Nahhas.
Investors · 6
How we know: Debiopharm Innovation Fund's portfolio page · the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Neulogy Ventures's portfolio page · the company's own site · Not right? Tell us
How we know: PICUS CAPITAL's portfolio page · the company's own site · a partner's Signal profile · Not right? Tell us
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does StratifAI do?
- StratifAI develops AI-driven multimodal biomarkers for precision oncology, using its platform to link routine H&E histology and RNASeq gene expression data to patient outcomes for prognostic and predictive insights. Its offerings target cancer diagnostics for oncology institutions and pharmaceutical companies, with an initial focus on breast cancer recurrence risk.
- Who founded StratifAI?
- StratifAI was founded by Daniel Truhn, Firas Khader, Jakob Nikolas Kather, Omar El Nahhas in 2023.
- Who are StratifAI's investors?
- StratifAI's investors include Debiopharm Innovation Fund, Neulogy Ventures, PICUS CAPITAL, Alven, Heliad AG, HV Capital.
- Where is StratifAI headquartered?
- StratifAI is headquartered in Berlin, DE.